Apotea AB (publ) (STU:V30) Other Financing: €-0.0 Mil (TTM As of Mar. 2026)


STU:V30 Apotea AB (publ) STU:V30
18 GF Score
Price €6.77
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Other Financing?

Apotea AB (publ) STU:V30 +0.74% 18 Other Financing is €-0.0 Mil as of Mar. 2026. GuruFocus rates STU:V30 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Other Financing for the three months ended in Mar. 2026 was €0.0 Mil.

Apotea AB (publ)'s Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.0 Mil.

Apotea AB (publ) Other Financing Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Other Financing Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
-0.64 -0.46 -0.78 -0.04 0.00

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
STU:V30
18GF Score
Apotea AB (publ) STU:V30
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-0.0 Mil mean?
Apotea AB (publ) (STU:V30) has a Other Financing of €-0.0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Other Financing too high?
Apotea AB (publ)'s current Other Financing is €-0.0 Mil. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Other Financing compare to competitors?
Apotea AB (publ)'s Other Financing of €-0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Other Financing is €-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (STU:V30) has a current Other Financing of €-0.0 Mil. The current Other Financing is €-0.0 Mil. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Apotea AB (publ) (STU:V30), the current Other Financing is €-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:Sweden
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score

Get the complete analysis for STU:V30

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.77
Price